Achalasia-addisonianism-alacrima syndrome |
AAAS |
CNV |
Harlequin ichthyosis |
ABCA12 |
CNV |
Stargardt disease, type 1 |
ABCA4 |
CNV |
Progressive familial intrahepatic cholestasis, type 2 |
ABCB11 |
CNV |
Progressive familial intrahepatic cholestasis, type 3 |
ABCB4 |
CNV |
Pseudoxanthoma elasticum |
ABCC6 |
CNV |
Familial hyperinsulinism, ABCC8-related |
ABCC8 |
CNV |
Adrenoleukodystrophy, X-linked |
ABCD1 |
CNV |
Mitochondrial complex I deficiency, ACAD9-related |
ACAD9 |
CNV |
Medium chain acyl-CoA dehydrogenase deficiency |
ACADM |
CNV |
Short chain acyl-CoA dehydrogenase deficiency |
ACADS |
CNV |
Short/branched chain acyl-CoA dehydrogenase deficiency |
ACADSB |
CNV |
Very long chain acyl-CoA dehydrogenase deficiency |
ACADVL |
CNV |
Beta-ketothiolase deficiency |
ACAT1 |
CNV |
Acyl-CoA oxidase I deficiency |
ACOX1 |
CNV |
Combined malonic and methylmalonic aciduria |
ACSF3 |
CNV |
Severe combined immunodeficiency, ADA-related |
ADA |
CNV |
Ehlers-Danlos syndrome, type VIIC |
ADAMTS2 |
CNV |
Bilateral frontoparietal polymicrogyria |
ADGRG1 |
CNV |
Aspartylglucosaminuria |
AGA |
CNV |
Glycogen storage disease, type III (Cori/Forbes) |
AGL |
CNV |
Rhizomelic chondrodysplasia punctata, type 3 |
AGPS |
CNV |
Hyperoxaluria, primary, type 1 |
AGXT |
CNV |
Autoimmune polyendocrinopathy syndrome, type I |
AIRE |
CNV |
Sjögren-Larsson syndrome |
ALDH3A2 |
CNV |
Pyridoxine-dependent epilepsy |
ALDH7A1 |
CNV |
Hereditary fructose intolerance |
ALDOB |
CNV |
Congenital disorder of glycosylation, type 1C |
ALG6 |
CNV |
Alström syndrome |
ALMS1 |
CNV |
Hypophosphatasia, ALPL-related |
ALPL |
CNV |
Persistent Müllerian duct syndrome, type 1 |
AMH |
CNV |
Persistent Müllerian duct syndrome, type 2 |
AMHR2 |
CNV |
Glycine encephalopathy, AMT-related |
AMT |
CNV |
Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma (MEDNIK) |
AP1S1 |
CNV |
Familial nephrogenic diabetes insipidus, AQP2-related |
AQP2 |
CNV |
Androgen insensitivity syndrome, X-linked |
AR |
CNV |
Argininemia |
ARG1 |
CNV |
Metachromatic leukodystrophy, ARSA-related |
ARSA |
CNV |
Mucopolysaccharidosis, type VI (Maroteaux-Lamy) |
ARSB |
CNV |
Argininosuccinate lyase deficiency |
ASL |
CNV |
Asparagine synthetase deficiency |
ASNS |
CNV |
Canavan disease |
ASPA |
CNV |
Citrullinemia, type 1 |
ASS1 |
CNV |
Ataxia-telangiectasia |
ATM |
CNV+ |
Renal tubular acidosis and deafness, ATP6V1B1-related |
ATP6V1B1 |
CNV |
Menkes syndrome, X-linked |
ATP7A |
CNV |
Wilson disease |
ATP7B |
CNV |
Progressive familial intrahepatic cholestasis, type 1 |
ATP8B1 |
CNV |
Alpha-thalassemia intellectual disability syndrome, X-linked |
ATRX |
CNV |
Bardet-Biedl syndrome 1 |
BBS1 |
CNV |
Bardet-Biedl syndrome 10 |
BBS10 |
CNV |
Bardet-Biedl syndrome 12 |
BBS12 |
CNV |
Bardet-Biedl syndrome 2 |
BBS2 |
CNV |
Bardet-Biedl syndrome 4 |
BBS4 |
CNV+ |
Bardet-Biedl syndrome 9 |
BBS9 |
CNV |
Pseudocholinesterase deficiency |
BCHE |
CNV |
Maple syrup urine disease, type 1A |
BCKDHA |
CNV |
Maple syrup urine disease, type 1B |
BCKDHB |
CNV |
GRACILE syndrome |
BCS1L |
CNV |
Bloom syndrome |
BLM |
CNV |
Fanconi anemia, group J |
BRIP1 |
CNV |
Bartter syndrome, type 4a |
BSND |
CNV |
Biotinidase deficiency |
BTD |
CNV |
Isolated growth hormone deficiency, type III, X-linked |
BTK |
CNV |
Desbuquois dysplasia 1 |
CANT1 |
CNV |
Limb-girdle muscular dystrophy, type 2A |
CAPN3 |
CNV |
Catecholaminergic polymorphic ventricular tachycardia |
CASQ2 |
CNV |
Homocystinuria, CBS-related |
CBS |
CNV |
Mental retardation, autosomal recessive 3 |
CC2D1A |
CNV+ |
Usher syndrome, type 1D |
CDH23 |
CNV |
Leber congenital amaurosis, type CEP290 |
CEP290 |
CNV |
Retinitis pigmentosa 26 |
CERKL |
CNV |
Cystic fibrosis |
CFTR |
CNV+ |
Choroideremia, X-linked |
CHM |
CNV |
Congenital myasthenic syndrome, CHRNE-related |
CHRNE |
CNV |
Escobar syndrome |
CHRNG |
CNV |
Bare lymphocyte syndrome, CIITA-related |
CIITA |
CNV |
Ceroid lipofuscinosis, neuronal, 3 |
CLN3 |
CNV+ |
Ceroid lipofuscinosis, neuronal, 5 |
CLN5 |
CNV |
Ceroid lipofuscinosis, neuronal, 6 |
CLN6 |
CNV |
Ceroid lipofuscinosis, neuronal, 8 (a.k.a. Northern epilepsy) |
CLN8 |
CNV |
Usher syndrome, type 3 |
CLRN1 |
CNV |
Achromatopsia, CNGA3-related |
CNGA3 |
CNV |
Achromatopsia, CNGB3-related |
CNGB3 |
CNV |
Fibrochondrogenesis, type 2 |
COL11A2 |
CNV |
Alport syndrome, COL4A3-related |
COL4A3 |
CNV |
Alport syndrome, COL4A4-related |
COL4A4 |
CNV |
Alport syndrome, X-linked |
COL4A5 |
CNV |
Dystrophic epidermolysis bullosa, COL7A1-related |
COL7A1 |
CNV |
Carbamoyl phosphate synthetase I deficiency |
CPS1 |
CNV |
Carnitine palmitoyltransferase IA deficiency |
CPT1A |
CNV |
Carnitine palmitoyltransferase II deficiency |
CPT2 |
CNV |
Leber congenital amaurosis 8 |
CRB1 |
CNV |
Cystinosis |
CTNS |
CNV+ |
Papillon-Lefevre syndrome |
CTSC |
CNV |
Ceroid lipofuscinosis, neuronal, 10 (CLN10 disease) |
CTSD |
CNV |
Pycnodysostosis |
CTSK |
CNV |
Chronic granulomatous disease, CYBA-related |
CYBA |
CNV |
Chronic granulomatous disease, X-linked |
CYBB |
CNV |
Congenital adrenal hyperplasia, 11-beta-hydroxylase-deficient |
CYP11B1 |
CNV |
Corticosterone methyloxidase deficiency |
CYP11B2 |
CNV |
Congenital adrenal hyperplasia, 17-alpha-hydroxylase deficiency |
CYP17A1 |
CNV |
Aromatase deficiency |
CYP19A1 |
CNV |
Primary congenital glaucoma |
CYP1B1 |
CNV |
Congenital adrenal hyperplasia, 21-hydroxylase-deficient |
CYP21A2 |
SC |
Cerebrotendinous xanthomatosis |
CYP27A1 |
CNV |
Vitamin D–dependent rickets, type 1A |
CYP27B1 |
CNV |
Maple syrup urine disease, type 2 |
DBT |
CNV |
Severe combined immunodeficiency, type athabaskan |
DCLRE1C |
CNV |
Xeroderma pigmentosum group E |
DDB2 |
CNV |
Smith-Lemli-Opitz syndrome |
DHCR7 |
CNV |
Retinitis pigmentosa 59 |
DHDDS |
CNV |
Dyskeratosis congenita, X-linked |
DKC1 |
CNV |
Dihydrolipoamide dehydrogenase deficiency |
DLD |
CNV |
Duchenne/Becker muscular dystrophy |
DMD |
CNV+ |
Ciliary dyskinesia, primary 3 |
DNAH5 |
CNV |
Ciliary dyskinesia, primary 1 |
DNAI1 |
CNV |
Ciliary dyskinesia, primary 9 |
DNAI2 |
CNV |
Ciliary dyskinesia, primary, 16 |
DNAL1 |
CNV |
Congenital myasthenic syndrome, DOK7-related |
DOK7 |
CNV |
Dihydropyrimidine dehydrogenase deficiency |
DPYD |
CNV |
Limb-girdle muscular dystrophy, type 2B |
DYSF |
CNV |
Hypohidrotic ectodermal dysplasia, X-linked |
EDA |
CNV |
Hypohidrotic ectodermal dysplasia |
EDAR |
CNV |
Wolcott-Rallison syndrome |
EIF2AK3 |
CNV |
Leukoencephalopathy with vanishing white matter |
EIF2B5 |
CNV |
Emery-Dreifuss muscular dystrophy 1, X-linked |
EMD |
CNV |
Xeroderma pigmentosum, group D |
ERCC2 |
CNV |
Xeroderma pigmentosum, group B |
ERCC3 |
CNV |
Xeroderma pigmentosum, group F |
ERCC4 |
CNV |
Xeroderma pigmentosum, group G |
ERCC5 |
CNV |
Cockayne syndrome, type B |
ERCC6 |
CNV |
Cockayne syndrome, type A |
ERCC8 |
CNV |
Roberts syndrome |
ESCO2 |
CNV |
Glutaric acidemia, type 2A |
ETFA |
CNV |
Glutaric acidemia, type 2B |
ETFB |
CNV |
Glutaric acidemia, type 2C |
ETFDH |
CNV |
Ethylmalonic encephalopathy |
ETHE1 |
CNV |
Ellis-van Creveld syndrome, EVC-related |
EVC |
CNV |
Ellis-van Creveld syndrome, EVC2-related |
EVC2 |
CNV |
Pontocerebellar hypoplasia, type 1B |
EXOSC3 |
CNV |
Retinitis pigmentosa 25 |
EYS |
CNV |
Factor XI deficiency |
F11 |
CNV |
Prothrombin deficiency |
F2 |
CNV |
Hemophilia A |
F8 |
CNV |
Hemophilia B |
F9 |
CNV |
Tyrosinemia, type I |
FAH |
CNV |
Retinitis pigmentosa 28 |
FAM161A |
CNV |
Fanconi anemia, group A |
FANCA |
CNV+ |
Fanconi anemia, group C |
FANCC |
CNV+ |
Fanconi anemia, group G |
FANCG |
CNV |
Fumarase deficiency |
FH |
CNV |
Limb-girdle muscular dystrophy, type 2I |
FKRP |
CNV |
Walker-Warburg syndrome, FKTN-related |
FKTN |
CNV |
Glycogen storage disease, type IA |
G6PC |
CNV |
Glucose-6-phosphate dehydrogenase deficiency |
G6PD |
CNV |
Glycogen storage disease, type II (Pompe disease) |
GAA |
CNV+ |
Krabbe disease |
GALC |
CNV+ |
Galactose epimerase deficiency |
GALE |
CNV |
Galactokinase deficiency (galactosemia, type II) |
GALK1 |
CNV |
Mucopolysaccharidosis, type IVA |
GALNS |
CNV |
Hyperphosphatemic familial tumoral calcinosis |
GALNT3 |
CNV |
Galactosemia |
GALT |
CNV+ |
Guanidinoacetate methyltransferase deficiency |
GAMT |
CNV |
Gaucher disease |
GBA |
CNV |
Glycogen storage disease, type IV |
GBE1 |
CNV |
Glutaric acidemia, type 1 |
GCDH |
CNV |
Dopa-responsive dystonia |
GCH1 |
CNV |
Grebe syndrome |
GDF5 |
CNV |
Combined oxidative phosphorylation deficiency 1 |
GFM1 |
CNV |
Isolated growth hormone deficiency, type IA/II |
GH1 |
CNV+ |
Isolated growth hormone deficiency, type IB |
GHRHR |
CNV |
Charcot-Marie-Tooth disease with deafness, X-linked |
GJB1 |
CNV |
Non-syndromic hearing loss (a.k.a. connexin 26) |
GJB2 |
CNV+ |
Erythrokeratodermia variabilis et progressiva |
GJB3 |
CNV |
Non-syndromic hearing loss (a.k.a. connexin 30) |
GJB6 |
CNV+ |
Fabry disease |
GLA |
CNV+ |
Mucopolysaccharidosis, type IVB / GM1 gangliosidosis |
GLB1 |
CNV |
Glycine encephalopathy, GLDC-related |
GLDC |
CNV |
Lethal congenital contracture syndrome 1 |
GLE1 |
CNV |
Inclusion body myopathy 2 |
GNE |
CNV |
Mucolipidosis II/IIIA |
GNPTAB |
CNV |
Mucolipidosis III gamma |
GNPTG |
CNV |
Mucopolysaccharidosis, type IIID (Sanfilippo D) |
GNS |
CNV |
Geroderma osteodysplastica |
GORAB |
CNV |
Bernard-Soulier syndrome, type A2 |
GP1BA |
CNV |
Bernard-Soulier syndrome, type B |
GP1BB |
CNV |
Bernard-Soulier syndrome, type C |
GP9 |
CNV |
Primary hyperoxaluria, type 2 |
GRHPR |
CNV |
Leber congenital amaurosis 1 |
GUCY2D |
CNV |
Mucopolysaccharidosis, type VII |
GUSB |
CNV |
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
HADHA |
CNV |
Trifunctional protein deficiency |
HADHB |
CNV |
Congenital neutropenia, HAX1-related |
HAX1 |
CNV |
Alpha-thalassemia |
HBA1 |
SC |
Alpha-thalassemia |
HBA2 |
SC |
Beta-hemoglobinopathies |
HBB |
CNV+ |
Tay-Sachs disease |
HEXA |
CNV+ |
Sandhoff disease |
HEXB |
CNV |
Hemochromatosis, type 1 |
HFE |
CNV |
Hemochromatosis, type 2A |
HFE2 |
CNV |
Alkaptonuria |
HGD |
CNV |
Mucopolysaccharidosis, type IIIC (Sanfilippo C) |
HGSNAT |
CNV |
Holocarboxylase synthetase deficiency |
HLCS |
CNV |
3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency |
HMGCL |
CNV |
Heme oxygenase-1 deficiency |
HMOX1 |
CNV |
Primary hyperoxaluria, type 3 |
HOGA1 |
CNV |
Tyrosinemia, type 3 |
HPD |
CNV |
Hermansky-Pudlak syndrome 1 |
HPS1 |
CNV |
Hermansky-Pudlak syndrome 3 |
HPS3 |
CNV |
Hermansky-Pudlak syndrome 4 |
HPS4 |
CNV |
17-beta hydroxysteroid dehydrogenase 3 deficiency |
HSD17B3 |
CNV |
D-bifunctional protein deficiency |
HSD17B4 |
CNV |
3-beta-hydroxysteroid dehydrogenase type II deficiency |
HSD3B2 |
CNV |
Hydrolethalus syndrome |
HYLS1 |
CNV |
Mucopolysaccharidosis, type II (Hunter syndrome) |
IDS |
CNV |
Mucopolysaccharidosis, type I (Hurler syndrome) |
IDUA |
CNV |
Dysautonomia, familial (IKBKAP or ELP1) |
IKBKAP |
CNV |
Severe combined immunodeficiency, X-linked |
IL2RG |
CNV |
Glanzmann thrombasthenia |
ITGB3 |
CNV+ |
Isovaleric acidemia |
IVD |
CNV |
Congenital hyperinsulinism, KCNJ11-related |
KCNJ11 |
CNV |
LAMA2-related muscular dystrophy |
LAMA2 |
CNV |
Herlitz junctional epidermolysis bullosa, LAMA3-related |
LAMA3 |
CNV |
Herlitz junctional epidermolysis bullosa, LAMB3-related |
LAMB3 |
CNV |
Herlitz junctional epidermolysis bullosa, LAMC2-related |
LAMC2 |
CNV |
Leber congenital amaurosis, type LCA5 |
LCA5 |
CNV |
Familial hypercholesterolemia, LDLR-related |
LDLR |
CNV |
Familial hypercholesterolemia, LDLRAP1-related |
LDLRAP1 |
CNV |
Leydig cell hypoplasia |
LHCGR |
CNV |
Stuve-Wiedemann syndrome |
LIFR |
CNV |
Lysosomal acid lipase deficiency |
LIPA |
CNV |
Woolly hair/hypotrichosis syndrome |
LIPH |
CNV |
Deafness, autosomal recessive 77 |
LOXHD1 |
CNV |
Lipoprotein lipase deficiency |
LPL |
CNV |
Leigh syndrome, French-Canadian type |
LRPPRC |
CNV |
Chediak-Higashi syndrome |
LYST |
CNV |
Alpha-mannosidosis |
MAN2B1 |
CNV |
Hypermethioninemia |
MAT1A |
CNV |
3-methylcrotonyl-CoA carboxylase 1 deficiency |
MCCC1 |
CNV |
3-methylcrotonyl-CoA carboxylase 2 deficiency |
MCCC2 |
CNV |
Mucolipidosis, type IV |
MCOLN1 |
CNV+ |
RETT syndrome |
MECP2 |
CNV |
Microcephaly, postnatal progressive, with seizures and brain atrophy |
MED17 |
CNV |
Familial Mediterranean fever |
MEFV |
CNV |
Spondylothoracic dysostosis, MESP2-related |
MESP2 |
CNV |
Ceroid lipofuscinosis, neuronal, 7 |
MFSD8 |
CNV |
Bardet-Biedl syndrome 6 |
MKKS |
CNV |
Meckel-Gruber syndrome, type 1 |
MKS1 |
CNV |
Megalencephalic leukoencephalopathy with subcortical cysts |
MLC1 |
CNV |
Malonyl-CoA decarboxylase deficiency |
MLYCD |
CNV |
Methylmalonic aciduria, MMAA-related |
MMAA |
CNV |
Methylmalonic aciduria, MMAB-related |
MMAB |
CNV |
Methylmalonic aciduria and homocystinuria, type cblC |
MMACHC |
CNV |
Methylmalonic aciduria and homocystinuria, type cblD |
MMADHC |
CNV |
Molybdenum cofactor deficiency |
MOCS1 |
CNV |
Congenital disorder of glycosylation, type 1B |
MPI |
CNV |
Congenital amegakaryocytic thrombocytopenia |
MPL |
CNV |
Hepatocerebral mitochondrial DNA depletion syndrome, MPV17-related |
MPV17 |
CNV |
Ataxia-telangiectasia-like disorder 1 |
MRE11 |
CNV |
Homocystinuria due to deficiency of MTHFR |
MTHFR |
CNV |
Myotubular myopathy, X-linked |
MTM1 |
CNV |
Homocystinuria, type cblE |
MTRR |
CNV |
Abetalipoproteinemia |
MTTP |
CNV |
Methylmalonic aciduria, type mut(0) |
MUT |
CNV |
Deafness, autosomal recessive, 3 |
MYO15A |
CNV |
Usher syndrome, type 1B |
MYO7A |
CNV |
Mucopolysaccharidosis, type IIIB (Sanfilippo B) |
NAGLU |
CNV |
N-acetylglutamate synthase deficiency |
NAGS |
CNV |
Nijmegen breakage syndrome |
NBN |
CNV |
Charcot-Marie-Tooth disease type 4D |
NDRG1 |
CNV |
Mitochondrial complex I deficiency, NDUFAF5-related |
NDUFAF5 |
CNV |
Mitochondrial complex I deficiency |
NDUFS4 |
CNV |
Mitochondrial complex I deficiency, NDUFS6-related |
NDUFS6 |
CNV |
Nemaline myopathy, NEB-related |
NEB |
CNV+ |
Sialidosis |
NEU1 |
CNV |
Hydatidiform mole, recurrent |
NLRP7 |
CNV |
Niemann-Pick disease, type C1/D |
NPC1 |
CNV |
Niemann-Pick disease, type C2 |
NPC2 |
CNV |
Juvenile nephronophthisis |
NPHP1 |
CNV |
Congenital Finnish nephrosis |
NPHS1 |
CNV |
Steroid-resistant nephrotic syndrome |
NPHS2 |
CNV |
Congenital adrenal hypoplasia, X-linked |
NR0B1 |
CNV |
Enhanced S-cone syndrome |
NR2E3 |
CNV |
Congenital insensitivity to pain with anhidrosis (CIPA) |
NTRK1 |
CNV |
Ornithine aminotransferase deficiency |
OAT |
CNV |
Lowe syndrome, X-linked |
OCRL |
CNV |
Costeff syndrome (3-methylglutaconic aciduria, type 3) |
OPA3 |
CNV |
Ornithine transcarbamylase deficiency |
OTC |
CNV |
Phenylketonuria |
PAH |
CNV+ |
Pantothenate kinase-associated neurodegeneration |
PANK2 |
CNV |
Pyruvate carboxylase deficiency |
PC |
CNV |
Propionic acidemia, PCCA-related |
PCCA |
CNV |
Propionic acidemia, PCCB-related |
PCCB |
CNV |
Usher syndrome, type 1F |
PCDH15 |
CNV+ |
Pyruvate dehydrogenase deficiency, X-linked |
PDHA1 |
CNV |
Pyruvate dehydrogenase deficiency, PDHB-related |
PDHB |
CNV |
Prolidase deficiency |
PEPD |
CNV |
Cytochrome-c oxidase deficiency |
PET100 |
CNV |
Peroxisome biogenesis disorder 1A (Zellweger) |
PEX1 |
CNV |
Peroxisome biogenesis disorder 6A (Zellweger) |
PEX10 |
CNV |
Peroxisome biogenesis disorder 3A (Zellweger) |
PEX12 |
CNV |
Peroxisome biogenesis disorder 5A (Zellweger) |
PEX2 |
CNV |
Peroxisome biogenesis disorder 4A (Zellweger) |
PEX6 |
CNV |
Rhizomelic chondrodysplasia punctata, type 1 |
PEX7 |
CNV |
Glycogen storage disease, type VII |
PFKM |
CNV |
Phosphoglycerate dehydrogenase deficiency |
PHGDH |
CNV |
Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
PIGN |
CNV |
Polycystic kidney disease, autosomal recessive |
PKHD1 |
CNV |
Infantile neuroaxonal dystrophy 1 |
PLA2G6 |
CNV |
Congenital disorder of glycosylation, type 1A, PMM2-related |
PMM2 |
CNV |
Pyridoxal 5ʹ-phosphate-dependent epilepsy |
PNPO |
CNV |
POLG-related disorders |
POLG |
CNV |
Xeroderma pigmentosum variant |
POLH |
CNV |
Muscle-eye-brain disease, POMGNT1-related |
POMGNT1 |
CNV |
Cytochrome P450 oxidoreductase deficiency |
POR |
CNV |
Ceroid lipofuscinosis, neuronal, 1 |
PPT1 |
CNV |
Myasthenic syndrome, congenital, 22 |
PREPL |
CNV+ |
Combined pituitary hormone deficiency 2 |
PROP1 |
CNV |
Arts syndrome, X-linked |
PRPS1 |
CNV |
Metachromatic leukodystrophy, PSAP-related |
PSAP |
CNV |
6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency |
PTS |
CNV |
Mitochondrial myopathy and sideroblastic anemia (MLASA1) |
PUS1 |
CNV |
Glycogen storage disease, type V (McArdle disease) |
PYGM |
CNV |
Carpenter syndrome |
RAB23 |
CNV |
Omenn syndrome, RAG1-related |
RAG1 |
CNV |
Omenn syndrome, RAG2-related |
RAG2 |
CNV |
Congenital myasthenic syndrome, RAPSN-related |
RAPSN |
CNV |
Pontocerebellar hypoplasia, type 1 and 6, RARS2-related |
RARS2 |
CNV |
Leber congenital amaurosis, type RDH12 |
RDH12 |
CNV |
Retinal dystrophies, RLBP1-associated |
RLBP1 |
CNV |
Cartilage-hair hypoplasia |
RMRP |
CNV |
Aicardi-Goutieres syndrome, RNASEH2C-related |
RNASEH2C |
CNV |
Leber congenital amaurosis 2 |
RPE65 |
CNV |
Ciliopathies, RPGRIP1L-related |
RPGRIP1L |
CNV |
Juvenile retinoschisis, X-linked |
RS1 |
CNV |
Dyskeratosis congenita, RTEL1-related |
RTEL1 |
CNV |
Autosomal recessive spastic ataxia of Charlevoix-Saguenay |
SACS |
CNV |
MIRAGE syndrome |
SAMD9 |
CNV |
Aicardi-Goutires syndrome |
SAMHD1 |
CNV+ |
Shwachman-Diamond syndrome |
SBDS |
CNV |
Pontocerebellar hypoplasia, type 2D |
SEPSECS |
CNV |
Alpha-1-antitrypsin deficiency |
SERPINA1 |
CNV |
Limb-girdle muscular dystrophy, type 2D |
SGCA |
CNV |
Limb-girdle muscular dystrophy, type 2E |
SGCB |
CNV |
Limb-girdle muscular dystrophy, type 2F |
SGCD |
CNV |
Limb-girdle muscular dystrophy, type 2C |
SGCG |
CNV |
Mucopolysaccharidosis, type IIIA (Sanfilippo A) |
SGSH |
CNV |
Gitelman syndrome |
SLC12A3 |
CNV |
Agenesis of the corpus callosum with peripheral neuropathy (Andermann syndrome) |
SLC12A6 |
CNV |
Salla disease |
SLC17A5 |
CNV |
Megaloblastic anemia syndrome |
SLC19A2 |
CNV |
Carnitine deficiency |
SLC22A5 |
CNV |
Citrullinemia, type II |
SLC25A13 |
CNV |
Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome |
SLC25A15 |
CNV |
Carnitine-acylcarnitine translocase deficiency |
SLC25A20 |
CNV |
Achondrogenesis, type 1B |
SLC26A2 |
CNV |
Congenital chloride diarrhea |
SLC26A3 |
CNV |
Pendred syndrome |
SLC26A4 |
CNV |
Autism spectrum, epilepsy, and arthrogryposis |
SLC35A3 |
CNV |
Glycogen storage disease, type IB |
SLC37A4 |
CNV |
Acrodermatitis enteropathica |
SLC39A4 |
CNV |
Cystinuria, type A |
SLC3A1 |
CNV+ |
Oculocutaneous albinism, type 4 |
SLC45A2 |
CNV |
Corneal dystrophy and perceptive deafness |
SLC4A11 |
CNV |
Creatine transporter defect (cerebral creatine deficiency syndrome 1, X-linked) |
SLC6A8 |
CNV |
Lysinuric protein intolerance |
SLC7A7 |
CNV |
Cystinuria, type B |
SLC7A9 |
CNV |
Schimke immunoosseous dysplasia |
SMARCAL1 |
CNV |
Spinal muscular atrophy |
SMN1 |
SC |
Niemann-Pick disease, types A/B |
SMPD1 |
CNV |
5-alpha reductase deficiency |
SRD5A2 |
CNV |
GM3 synthase deficiency |
ST3GAL5 |
CNV |
Lipoid congenital adrenal hyperplasia |
STAR |
CNV |
Deafness, autosomal recessive 16 |
STRC |
CNV+ |
Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria) |
SUCLA2 |
CNV |
Multiple sulfatase deficiency |
SUMF1 |
CNV |
Leigh syndrome |
SURF1 |
CNV |
Tyrosinemia, type II |
TAT |
CNV |
Osteopetrosis, infantile malignant, TCIRG1-related |
TCIRG1 |
CNV |
Hereditary spastic paraparesis, type 49 |
TECPR2 |
CNV |
Hemochromatosis, type 3, TFR2-related |
TFR2 |
CNV |
Lamellar ichthyosis, type 1 |
TGM1 |
CNV |
Segawa syndrome, TH-related |
TH |
CNV |
Deafness, autosomal dominant 36, autosomal recessive 7 |
TMC1 |
CNV |
Joubert syndrome 2/Meckel syndrome 2 |
TMEM216 |
CNV |
Congenital hypothyroidism |
TPO |
CNV |
Ceroid lipofuscinosis, neuronal, 2 |
TPP1 |
CNV |
Aicardi-Goutieres syndrome, TREX1-related |
TREX1 |
CNV |
Bardet-Biedl syndrome 11 |
TRIM32 |
CNV |
Mulibrey nanism syndrome |
TRIM37 |
CNV |
Acute infantile liver failure, TRMU-related |
TRMU |
CNV |
Pontocerebellar hypoplasia |
TSEN54 |
CNV |
Combined oxidative phosphorylation deficiency 3 |
TSFM |
CNV |
Congenital hypothyroidism |
TSHB |
CNV |
Hypothyroidism, congenital, nongoitrous, 1 |
TSHR |
CNV |
Tricho-hepato-enteric syndrome |
TTC37 |
CNV |
Familial dilated cardiomyopathy |
TTN |
CNV |
Ataxia with vitamin E deficiency |
TTPA |
CNV |
Myoneurogastrointestinal encephalopathy (MNGIE) |
TYMP |
CNV |
Oculocutaneous albinism, type 1 |
TYR |
CNV |
Oculocutaneous albinism, type 3 |
TYRP1 |
CNV |
Crigler-Najjar syndrome |
UGT1A1 |
CNV |
Beta-ureidopropionase deficiency |
UPB1 |
CNV |
Usher syndrome, type 1C |
USH1C |
CNV |
Usher syndrome, type 2A |
USH2A |
CNV+ |
Choreo-acanthocytosis |
VPS13A |
CNV+ |
Cohen syndrome |
VPS13B |
CNV |
Congenital neutropenia, VPS45-related |
VPS45 |
CNV |
Pontocerebellar hypoplasia, type 2E |
VPS53 |
CNV |
Pontocerebellar hypoplasia, type 1A |
VRK1 |
CNV |
Microphthalmia/Anophthalmia, VSX2-related |
VSX2 |
CNV |
Von Willebrand disease |
VWF |
CNV |
Wiskott-Aldrich syndrome, X-linked |
WAS |
CNV |
Progressive pseudorheumatoid dysplasia |
WISP3 |
CNV |
Odonto-onycho-dermal dysplasia/Schopf-Schulz-Passarge syndrome |
WNT10A |
CNV |
Werner syndrome |
WRN |
CNV |
Xeroderma pigmentosum group A |
XPA |
CNV |
Xeroderma pigmentosum group C |
XPC |
CNV |
Spastic paraplegia type 15 |
ZFYVE26 |
CNV |